Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-25-075539

Director sold 3,000 shares at $107.49 ($322,473)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Coleman Mark Director 2025-05-20 Sale −3,000 $107.49 $322,473 54,137 D: show line 1 in the form
Open-market sales · 3,000 sh · avg $107.49 · $322,473
Loading xslF345X05/ownership.xml…